ABBREVIATE
- Name: ABBREVIATE
- Status: Ongoing
- Study design: De-Adoption βeta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a pragmaTic randomizEd trial with blinded endpoints (ABBREVIATE) is a multi-centre vanguard project taking place within Alberta.
- Logo : No logo
- Link for more study information: Study Details | De-Adoption of Beta-Blockers in Patients With Stable Ischemic Heart Disease | ClinicalTrials.gov
